HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Prognostic significance of scoring system based on histological heterogeneity of invasive ductal carcinoma for node-negative breast cancer patients.

Abstract
This study aimed to determine the prognostic significance of histological scoring system based on heterogeneity of invasive ductal carcinoma, for node-negative breast cancer patients. We studied 108 patients of node-negative invasive ductal carcinoma with invasive tumor >5 mm. Histological score of each patient was evaluated based on histological subtype of invasive ductal carcinoma and pattern of its heterogeneity. Score of each subtype was defined as follows; papillotubular carcinoma: score 1, solid-tubular carcinoma: score 2 and scirrhous carcinoma: score 3. The existence of histological heterogeneity was examined, and corresponding score was doubled in a pure case and scores of two dominant subtypes were summed in a composite case. Overall survival curves defined by sores were drawn by Kaplan-Meier method and the difference in survival rate was evaluated by log-rank test. The most significant difference of overall survival was recognized between low score group (scores 2, 3 and 4) and high score group (scores 5 and 6) (p<0.001). In addition, multivariate analysis confirmed that only histological score was an independent prognostic factor. These results suggested that assessment of histological heterogeneity of invasive ductal carcinoma could serve as independent potent prognostic factor for node-negative invasive ductal carcinoma of the breast, and this method might be useful to decide indication of postoperative adjuvant chemotherapy.
AuthorsMasafumi Kurosumi, Toshio Tabei, Kenichi Inoue, Hiroyuki Takei, Jun Ninomiya, Rin Naganuma, Kimito Suemasu, Yasuhiro Higashi, Eiju Tsuchiya
JournalOncology reports (Oncol Rep) 2003 Jul-Aug Vol. 10 Issue 4 Pg. 833-7 ISSN: 1021-335X [Print] Greece
PMID12792731 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Receptors, Estrogen
Topics
  • Adenocarcinoma (classification, metabolism, pathology)
  • Adenocarcinoma, Papillary (classification, metabolism, pathology)
  • Adenocarcinoma, Scirrhous (classification, metabolism, pathology)
  • Adult
  • Aged
  • Breast Neoplasms (classification, metabolism, pathology)
  • Carcinoma, Ductal, Breast (classification, metabolism, pathology)
  • Female
  • Humans
  • Immunoenzyme Techniques
  • Lymph Nodes (metabolism)
  • Middle Aged
  • Neoplasm Invasiveness
  • Prognosis
  • Receptors, Estrogen (metabolism)
  • Survival Rate

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: